glp 1 hepatic steatosis Why are GLP-1 agonists being used to treat patients with nonalcoholic fatty liver disease? SGLT-2 inhibitors and GLP-1 receptor

J Dermatolog Treat 33(3):14281434 Faurschou A et al (2015) Lack of effect of the glucagon-like peptide-1 receptor agonist liraglutide on psoriasis in glucose-tolerant patientsa randomized placebo-controlled trial

The market is forecast to record a 18.0% CAGR from 2026 to 2036 as titration support and side-effect management become part of routine care

Abstract Methanol synthesized from captured greenhouse gases is an emerging renewable feedstock with great potential for bioproduction

For a comprehensive overview of what to watch for, our peptide safety guide covers both common and rare concerns

Efficacy and safety of 650 nm invasive laser acupuncture on non-specific chronic low back pain: a randomised clinical trial